Bloomberg

Morgan Health CEO: Tech, GLP-1s, Labor Driving up Costs

Share

Dan Mendelson, CEO of Morgan Health, highlighted the disproportionate impact of rising health insurance costs on small businesses in the U.S., citing premium increases of 20-25% as a significant challenge. He explained that cost drivers include expensive new medical technologies like GLP-1 drugs and labor costs, which constitute about 70% of hospital expenses. He speaks with Romaine Bostick & Katie Greifeld on "The Close."

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.